TipRanks
Advertisement
Advertisement
Valbiotis SA’s TOTUM-448 Trial: A Potential Game-Changer for Liver Health
PremiumCompany AnnouncementsValbiotis SA’s TOTUM-448 Trial: A Potential Game-Changer for Liver Health
11M ago
Valbiotis Announces Monthly Voting Rights and Share Capital Update
Premium
Company Announcements
Valbiotis Announces Monthly Voting Rights and Share Capital Update
2y ago
Valbiotis Introduces Lipidrive as a Safe Alternative to Red Yeast Rice
Premium
Company Announcements
Valbiotis Introduces Lipidrive as a Safe Alternative to Red Yeast Rice
2y ago
Valbiotis Sets Ambitious 2030 Growth Targets with Focus on Natural Health Supplements
PremiumCompany AnnouncementsValbiotis Sets Ambitious 2030 Growth Targets with Focus on Natural Health Supplements
2y ago
Valbiotis Achieves Clinical Success with Lipidrive® for Cholesterol Management
Premium
Company Announcements
Valbiotis Achieves Clinical Success with Lipidrive® for Cholesterol Management
2y ago
Valbiotis Reports Half-Year Liquidity Contract Update
Premium
Company Announcements
Valbiotis Reports Half-Year Liquidity Contract Update
2y ago
Valbiotis Achieves Clinical Success with TOTUM•854
PremiumCompany AnnouncementsValbiotis Achieves Clinical Success with TOTUM•854
2y ago
Valbiotis SA Announces Latest Share Capital Data
Premium
Company Announcements
Valbiotis SA Announces Latest Share Capital Data
2y ago
Valbiotis Announces Latest Share and Voting Rights
Premium
Company Announcements
Valbiotis Announces Latest Share and Voting Rights
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100